Why the stock of this biotech has nearly tripled in 6 months
PhaseBio, a small biopharmaceuticals firm developing slow-release treatments for heart ailments at its offices in Malvern, Pa., and San Diego, has captured investors' imagination,…
PhaseBio, a small biopharmaceuticals firm developing slow-release treatments for heart ailments at its offices in Malvern, Pa., and San Diego, has captured investors' imagination,…